Literature DB >> 2416860

Induction of neovascularization by activated human monocytes.

A E Koch, P J Polverini, S J Leibovich.   

Abstract

Neovascularization, the process of new blood vessel growth, is an important feature of many pathologic and physiologic processes. Monocytes were isolated from citrated blood buffy coat of healthy adult human donors on Ficoll-Hypaque gradients. Mononuclear cells from these gradients were fractionated on discontinuous Percoll gradients; monocyte-enriched fractions were isolated and assessed for angiogenic activity in rat corneas. Freshly isolated monocytes as well as monocytes cultured for 20 hr on fibronectin-coated collagen gels failed to stimulate neovascularization. In contrast, adherent monocytes activated with concanavalin A (25 micrograms/ml) or endotoxin (5 micrograms/ml) for 20 hr were found to be potently angiogenic. We conclude that peripheral blood monocytes must be activated to acquire the ability to induce new blood vessel growth, a process central to inflammation, wound healing, and tumor development.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2416860     DOI: 10.1002/jlb.39.2.233

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  18 in total

1.  Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity.

Authors:  A E Koch; J C Burrows; P J Polverini; M Cho; S J Leibovich
Journal:  Agents Actions       Date:  1991-11

2.  Angiogenesis and inflammation in invasive carcinoma of the breast.

Authors:  A H Lee; L C Happerfield; L G Bobrow; R R Millis
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

3.  Erythropoiesis in chronic subdural haematomas.

Authors:  W Müller; E Zimmermann; R Firsching
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

4.  4A11, a monoclonal antibody recognizing a novel antigen expressed on aberrant vascular endothelium. Upregulation in an in vivo model of contact dermatitis.

Authors:  A E Koch; B J Nickoloff; J Holgersson; B Seed; G K Haines; J C Burrows; S J Leibovich
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

Review 5.  Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts.

Authors:  Bradley J Rabquer; Alisa E Koch
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

6.  Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1.

Authors:  L A DiPietro; P J Polverini
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.

Authors:  A E Koch; S L Kunkel; L A Harlow; B Johnson; H L Evanoff; G K Haines; M D Burdick; R M Pope; R M Strieter
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Significance of eosinophilic granulocytes in chronic subdural hematomas.

Authors:  W Müller; R Firsching
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

9.  Interleukin-8. A corneal factor that induces neovascularization.

Authors:  R M Strieter; S L Kunkel; V M Elner; C L Martonyi; A E Koch; P J Polverini; S G Elner
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

10.  Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macrophages.

Authors:  A E Koch; J C Burrows; A Skoutelis; R Marder; P H Domer; B Anderson; S J Leibovich
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.